IYIA Technologies

IYIA Technologies was a medical technology company specializing in advanced wound care solutions, particularly for patients suffering from diabetic foot ulcers. The company developed the O2Misly Wound Treatment System (also known as the WHS-1000), which utilized vaporous hyperoxia therapy to deliver humidified oxygen to chronic wounds. This FDA-cleared device was designed to promote healing and reduce the incidence of amputations by providing a localized hyperbaric environment. Founded in 2004 and headquartered in San Marcos, California, the company focused on integrating heat, moisture, and oxygen to treat non-healing wounds. The system was intended as an adjunct therapy for various conditions, including decubitus ulcers and infected stumps. IYIA Technologies is currently considered inactive or deadpooled.